| Dr Brooke Harmssen, DO | |
|
1650 East Chevy Chase Drive, Suite 355, Glendale, CA 91206-4159 | |
| (747) 212-3441 | |
| (747) 273-0965 |
| Full Name | Dr Brooke Harmssen |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1650 East Chevy Chase Drive, Glendale, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083110456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A17897 (California) | Secondary |
| 207R00000X | Internal Medicine | 20A17897 (California) | Primary |
| Entity Name | Galen Inpatient Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689320459 PECOS PAC ID: 3678464633 Enrollment ID: O20040322000680 |
News Archive
The New York Times reports that the whistleblowing of a former vice president of a research hospital in Urbana, Ill., has highlighted some questionable research practices at certain community cancer research sites.
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
Programmed cell death is an integral part of embryonic development. Exploring the regulation of the process, Ludwig-Maximilians-Universitaet in Munich researchers have shown that so-called microRNAs protect the precursors of neurons from 'precocious' elimination.
A new study deals with the screening of the Drug Repurposing Hub (DRH) library for identifying small compounds which are capable of inhibiting SARS-CoV-2 using both in vitro and in vivo experimental studies. These molecules could be used for designing a novel therapeutic system against SARS-CoV-2 infection.
› Verified 9 days ago
| Entity Name | Vituity - Primary Care Glendale Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548876626 PECOS PAC ID: 0547680688 Enrollment ID: O20201012001634 |
News Archive
The New York Times reports that the whistleblowing of a former vice president of a research hospital in Urbana, Ill., has highlighted some questionable research practices at certain community cancer research sites.
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
Programmed cell death is an integral part of embryonic development. Exploring the regulation of the process, Ludwig-Maximilians-Universitaet in Munich researchers have shown that so-called microRNAs protect the precursors of neurons from 'precocious' elimination.
A new study deals with the screening of the Drug Repurposing Hub (DRH) library for identifying small compounds which are capable of inhibiting SARS-CoV-2 using both in vitro and in vivo experimental studies. These molecules could be used for designing a novel therapeutic system against SARS-CoV-2 infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brooke Harmssen, DO 1650 East Chevy Chase Drive, Suite 355, Glendale, CA 91206-4159 Ph: (747) 212-3441 | Dr Brooke Harmssen, DO 1650 East Chevy Chase Drive, Suite 355, Glendale, CA 91206-4159 Ph: (747) 212-3441 |
News Archive
The New York Times reports that the whistleblowing of a former vice president of a research hospital in Urbana, Ill., has highlighted some questionable research practices at certain community cancer research sites.
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
Programmed cell death is an integral part of embryonic development. Exploring the regulation of the process, Ludwig-Maximilians-Universitaet in Munich researchers have shown that so-called microRNAs protect the precursors of neurons from 'precocious' elimination.
A new study deals with the screening of the Drug Repurposing Hub (DRH) library for identifying small compounds which are capable of inhibiting SARS-CoV-2 using both in vitro and in vivo experimental studies. These molecules could be used for designing a novel therapeutic system against SARS-CoV-2 infection.
› Verified 9 days ago
Tigran Khachatryan, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 660 W Broadway, Glendale, CA 91204 Phone: 818-243-9600 | |
Dr. Jean-pierre E Antaki, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 S Chevy Chase Dr, #105, Glendale, CA 91205 Phone: 818-242-5299 Fax: 818-637-7607 | |
Dr. Ellie Bloomfield, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1808 Verdugo Blvd, Suite 403, Glendale, CA 91208 Phone: 818-790-7098 Fax: 818-790-7099 | |
Edgar H Aleman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 435 Arden Ave, 410, Glendale, CA 91203 Phone: 818-242-4191 Fax: 818-242-4811 | |
Michael Eugene Klein, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1818 Verdugo Blvd, #300, Glendale, CA 91208 Phone: 818-952-5332 Fax: 818-790-6830 | |
Alen Mirzaian, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1818 Verdugo Blvd Ste 401, Glendale, CA 91208 Phone: 818-790-1145 | |
Dr. Thomas Yarger Pocock, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1809 Verdugo Blvd, #200, Glendale, CA 91208 Phone: 818-790-6700 Fax: 818-790-2816 |